COMMUNIQUÉS West-GlobeNewswire

Genmab Announces European Marketing Authorization for DARZALEX® (daratumumab) for Front Line Multiple Myeloma
31/08/2018
Company Announcement DARZALEX approved in Europe in combination with bortezomib, melphalan and prednisone in patients with newly diagnosed multiple myeloma Approval follows positive opinion by European Committee for [...]
Zynerba Pharmaceuticals to Present at the H.C. Wainwright 20th Annual Global Investment Conference
31/08/2018
DEVON, Pa., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]
Portola Pharmaceuticals Submits Prior Approval Supplement to U.S. FDA for Large-Scale Generation 2 Andexxa Process
31/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq:PTLA) today announced the submission of a prior approval supplement (PAS) to the U.S. Food and Drug Administration ( [...]
Selecta Biosciences Announces Presentation at the 20th Asia Pacific League of Associations for Rheumatology Congress (APLAR)
31/08/2018
WATERTOWN, Mass., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]
Rubius Therapeutics Reports Second Quarter 2018 Financial Results
31/08/2018
CAMBRIDGE, Mass., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, today reported second [...]
Altimmune Announces Initial Single-Dose Data from Its NasoShield Phase 1 Study
31/08/2018
Studies funded by BARDA GAITHERSBURG, Md., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced initial data from its Phase 1 study of NasoShield [...]
Atara Biotherapeutics to Participate at Two Upcoming Conferences
31/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 juillet 2018
31/08/2018
Communiqué de presse Villepinte, le 31 août 2018 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]
Myriad Genetics to Present at the 2018 Morgan Stanley Global Healthcare Conference
31/08/2018
SALT LAKE CITY, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled [...]
Midatech Announces Interim Results from Proof of Concept Exploratory Study for its MTD201 Q-Octreotide Programme and Q-Sphera™ Microsphere Technology
31/08/2018
31 August 2018 Midatech Pharma PLC ("Midatech" or the "Company") Midatech Announces Interim Results from Proof of Concept Exploratory Study for its MTD201 Q-Octreotide Programme and Q-Sphera™ Microsphere Technology [...]
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2018
31/08/2018
CRANBURY, N.J., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced upcoming presentations at two investor conferences in September. Bradley Campbell, President and Chief Operating [...]
Cerecor CEO to Present at the H.C. Wainwright Global Investment Conference
31/08/2018
BALTIMORE, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on the near-term goal of becoming a leader in the U.S. pediatric market space, today announced that the [...]
Auxly Announces Completion of KGK Science Acquisition
31/08/2018
VANCOUVER, British Columbia, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX: CBWTF) (" Auxly " or the " Company ") is pleased to announce that, further to its press release issued on [...]
BeiGene Announces Acceptance of New Drug Application for Anti-PD-1 Antibody Tislelizumab in Hodgkin’s Lymphoma in China
31/08/2018
BEIJING, China, and CAMBRIDGE, Mass., Aug. 31, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Ambu A/S: Articles of Association August 2018
31/08/2018
Articles of Association August 2018 Attachment Complete Articles of Association August 2018.pdf
Terveystalo Plc: Terveystalo appoints Julia Ormio as Senior Vice President, Legal
31/08/2018
Terveystalo Plc Stock Exchange release 31 August 2018 at 10:00 a.m. EEST Julia Ormio, born 1970, LL.B., LL.M, has been appointed as Senior Vice President, Legal of Terveystalo as of 1 December 2018. She becomes a member [...]
Ambu A/S: Capital increase in connection with exercise of warrants issued
31/08/2018
In December 2013, Ambu A/S issued 2,000,000 warrants and in December 2014 2,000,000 warrants, each warrant entitling the holder to subscribe for one Class B share with a nominal value of DKK 0.50. 52 individuals [...]
FIT Biotech Oy: NOTICE CONVENING AN EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY
31/08/2018
Company release August 31, 2018 at 09:30 AM EET NOTICE CONVENING AN EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY The shareholders of FIT Biotech Oy are invited to the Extraordinary General Meeting ("EGM"), which is [...]
Oasmia Pharmaceutical AB (publ) Interim report for the period May – July 2018
31/08/2018
FIRST QUARTER May 1 – July 31, 2018 Consolidated net sales amounted to TSEK 128 compared to TSEK 20 in the first quarter the previous year Operating loss was TSEK 26,572 compared to TSEK 28,421 in the first quarter the [...]

Pages